CMF-00738 | DNAH5 | up-regulates | MAFB | activates | R-1902 | 25 | 2 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-01049 | ZNF292 | down-regulates | MAFB | activates | R-1902 | 25 | 10 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-01168 | SKAP2 | up-regulates | MAFB | activates | R-1902 | 25 | 2 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-01603 | MCM6 | up-regulates | MAFB | activates | R-1902 | 25 | 7 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-02684 | SLC9A10 | down-regulates | MAFB | activates | R-1902 | 25 | 3 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-10021 | ATP8A2 | down-regulates | MAFB | activates | R-1902 | 25 | 10 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-10877 | SMARCA2 | up-regulates | MAFB | activates | R-1902 | 25 | 3 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-11400 | CYP4F22 | up-regulates | MAFB | activates | R-1902 | 25 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-14608 | C1orf177 | up-regulates | MAFB | activates | R-1902 | 25 | 1 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-16017 | NFIX | up-regulates | MAFB | activates | R-1902 | 25 | 9 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-17938 | PRPF40B | down-regulates | MAFB | activates | R-1902 | 25 | 10 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-19634 | RPSAP58 | up-regulates | MAFB | activates | R-1902 | 25 | 8 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-19690 | UGT2B4 | up-regulates | MAFB | activates | R-1902 | 25 | 4 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-20102 | TDRD9 | up-regulates | MAFB | activates | R-1902 | 25 | 7 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-21589 | MUC17 | up-regulates | MAFB | activates | R-1902 | 25 | 11 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-24304 | SMCHD1 | up-regulates | MAFB | activates | R-1902 | 25 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-24848 | NSUN5 | down-regulates | MAFB | activates | R-1902 | 25 | 5 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-27289 | CHD5 | up-regulates | MAFB | activates | R-1902 | 25 | 8 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-27578 | ANKRD36 | up-regulates | MAFB | activates | R-1902 | 25 | 10 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-30507 | JHDM1D | down-regulates | MAFB | activates | R-1902 | 25 | 6 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-31089 | LRFN2 | down-regulates | MAFB | activates | R-1902 | 25 | 4 | Drugs (29) Regulator Drugs (0)Regulon Drugs (29)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, HYDROXYCHLOROQUINE, R-343, AME-133V, R-348, CERDULATINIB, VESATOLIMOD, AZD-8848, EFALIZUMAB, HMPL-523, HYDROXYCHLOROQUINE SULFATE, PETESICATIB, ENTOSPLETINIB, CPG-52852, R-333, IMIQUIMOD, IC14, GUSACITINIB, LIFITEGRAST, VB-201, GSK-2245035, MIVAVOTINIB CITRATE, VELIFLAPON, TELRATOLIMOD, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |